EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, TSHA: Taysha Gene Therapies Inc

23 Oct 26 15:59
LAST:

3.965

CHANGE:
 0.05		OPEN:
3.990		HIGH:
4.040		ASK:
0.000		VOLUME:
1.93M
CHG(%):
1.12		PREV:
4.005		LOW:
3.755		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 263.9503.9803.7553.9602.59M
22 Oct 264.0704.1753.9354.0053.11M
21 Oct 264.1504.2654.0504.1203.51M
20 Oct 263.9504.2003.8904.11010.93M
19 Oct 263.6603.9653.6503.9405.82M
16 Oct 263.7303.7453.6003.6202.75M
15 Oct 263.5303.7903.5003.7304.69M
14 Oct 263.5103.7153.4553.5104.34M
13 Oct 264.0904.1303.5503.5806.12M
12 Oct 264.4604.5604.1254.1404.21M

PROFILE

Name:Taysha Gene Therapies Inc
About:Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:3000 Pegasus Park Drive, Dallas, TX, United States, 75247
Website:https://www.tayshagtx.com
CUSIP:877619106
CIK:0001806310
ISIN:US8776191061
FIGI:BBG00TJXFDP1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:2.53 
Forward P/E:-10.01 
PEG Ratio:-11.81 
Price to Sales:167.09 
Price to Book:6.27 
Operating Margin:-13.47 
Return on Assets:-0.21 
Return on Equity:-0.52 
EPS Ratio:-0.41 
Revenue:8.1M 
Shares:325.83M 
Market Cap:1.292B 

TECHNICAL INDICATORS

MA5:4.031.6%
MA10:3.872.4%
MA20:4.267.4%
MA50:5.0226.7%
MA100:5.5439.8%
MA200:5.3534.8%
STO9:59.60
STO14:42.45
RSI14:37.79 
WPR14:-54.08
MTM14:-0.43
ROC14:-0.10 
ATR:0.28 
Week High:4.277.6%
Week Low:3.6010.1%
Month High:5.1429.6%
Month Low:3.4634.8%
Year High:7.3084.1%
Year Low:3.4614.8%